全文获取类型
收费全文 | 2407303篇 |
免费 | 185906篇 |
国内免费 | 4898篇 |
专业分类
耳鼻咽喉 | 33624篇 |
儿科学 | 80195篇 |
妇产科学 | 69438篇 |
基础医学 | 347208篇 |
口腔科学 | 67069篇 |
临床医学 | 213476篇 |
内科学 | 472211篇 |
皮肤病学 | 53841篇 |
神经病学 | 193495篇 |
特种医学 | 92693篇 |
外国民族医学 | 794篇 |
外科学 | 365829篇 |
综合类 | 54376篇 |
现状与发展 | 4篇 |
一般理论 | 755篇 |
预防医学 | 186048篇 |
眼科学 | 55402篇 |
药学 | 176262篇 |
2篇 | |
中国医学 | 5207篇 |
肿瘤学 | 130178篇 |
出版年
2018年 | 25561篇 |
2017年 | 19381篇 |
2016年 | 21910篇 |
2015年 | 24860篇 |
2014年 | 34911篇 |
2013年 | 52404篇 |
2012年 | 71305篇 |
2011年 | 76021篇 |
2010年 | 44911篇 |
2009年 | 42523篇 |
2008年 | 71540篇 |
2007年 | 76573篇 |
2006年 | 77486篇 |
2005年 | 75466篇 |
2004年 | 72523篇 |
2003年 | 69518篇 |
2002年 | 67907篇 |
2001年 | 113480篇 |
2000年 | 116207篇 |
1999年 | 97607篇 |
1998年 | 28003篇 |
1997年 | 25189篇 |
1996年 | 25322篇 |
1995年 | 24012篇 |
1994年 | 22111篇 |
1993年 | 20788篇 |
1992年 | 76048篇 |
1991年 | 73699篇 |
1990年 | 71791篇 |
1989年 | 69239篇 |
1988年 | 63926篇 |
1987年 | 62653篇 |
1986年 | 59143篇 |
1985年 | 56471篇 |
1984年 | 42633篇 |
1983年 | 36633篇 |
1982年 | 22088篇 |
1981年 | 19659篇 |
1979年 | 39094篇 |
1978年 | 27694篇 |
1977年 | 23386篇 |
1976年 | 22209篇 |
1975年 | 23697篇 |
1974年 | 28188篇 |
1973年 | 27204篇 |
1972年 | 25663篇 |
1971年 | 23629篇 |
1970年 | 22241篇 |
1969年 | 21045篇 |
1968年 | 19783篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
971.
972.
Confounders contributing to the reported associations of coffee or caffeine with disease 总被引:2,自引:0,他引:2
G B Schreiber M Robins C E Maffeo M N Masters A P Bond D Morganstein 《Preventive medicine》1988,17(3):295-309
The role of caffeine or coffee in causing or promoting the incidence of serious disease is equivocal. Two design factors may account for the discrepancies in reported findings on the effects of coffee drinking: (a) imprecision of measurement and (b) confounding variables. A study of 2,714 white U.S. adults disclosed that, of 32 risk factors analyzed by linear and logistic regression, only sex and cigarette smoking were found to be important potential confounders of caffeine and coffee intake. Partial R2 values of the other 30 risk factors were relatively small and were inconsistent for each sex. It is unlikely that any of these factors could explain any of the reported associations between caffeine or coffee consumption and certain diseases. However, certain weak associations with caffeine or coffee intake should be included in the study design when they are known to be risk factors of a disease under investigation. These factors for men are dietary fat intake, vitamin C intake, and body mass index; and for women are vitamin use, alcohol intake, stress, and perceived health status. 相似文献
973.
This study investigates the contribution of body fat stores on the age-associated increase in serum cholesterol and triglyceride levels. Percentage of body fat was measured by hydrostatic weighing, and serum cholesterol, triglyceride, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol levels were determined in a sample of 472 healthy men and women ages 18-50 years. In both sexes, body fat mass was significantly correlated with serum cholesterol (r = 0.21 in men and r = 0.24 in women, P less than 0.01) and triglyceride (r = 0.33 in men and r = 0.24 in women, P less than 0.01) levels. After adjustment for the association between age and serum cholesterol, no correlation was observed between body fat mass and serum cholesterol (r = 0.01 in men and r = 0.09 in women). After correction for age, serum triglyceride levels remained significantly correlated with body fat mass (r = 0.26 and r = 0.17 in men and women, respectively, P less than 0.05). As body fat also increases with age, the possibility that a partial correlation coefficient procedure eliminated a portion of the age effect mediated by an age-related increase in fat, was addressed by performing further analyses. Within each sex subsample two sets of analyses were performed on (a) three groups of subjects individually paired for age but with different levels of body fat stores, and (b) three groups of subjects paired for the amount of body fat but differing in age.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
974.
Thomas E. Kottke Laël C. Gatewood Shu-Chen Wu Hyeoun-Ae Park 《Journal of clinical epidemiology》1988,41(11):1083-1093
Monte Carlo simulation was used to assess the effects of several intervention strategies on coronary heart disease mortality rates in a Finnish and a North American cohort. Lowering total serum cholesterol by 4%, smoking by 15%, and diastolic blood pressure by 3% for the whole cohort would be expected to reduce the incidence of non-fatal myocardial infarction by at least 13% and coronary heart disease deaths by at least 18%. Lowering serum cholesterol by 34%, diastolic blood pressure to 90 mmHg, and reducing smoking by 20% in the subset of the population with all three risk factors in the highest quartile would result in a 6-8% reduction in non-fatal myocardial infarction and a 2-9% reduction in deaths from coronary heart disease in these cohorts. These data demonstrate that in populations with a relatively high incidence of heart disease, treating the entire population will produce larger effects than focusing only on high-risk populations. 相似文献
975.
976.
977.
During recent decades there has been a controversial discussion if comparable plasma level profiles which are rather constant or those which show a high peak are more efficient for the cure of gonorrhoea. So far, investigations in this field were not based on the Grasso apparatus. Although the findings with cefotiam and ceftizoxime do not allow to formulate a general hypothesis without any restriction, it can be stated that on the basis of an identical area under the antibiotic level time curve, 'peak concentration' profiles are more favourable. 相似文献
978.
979.
N A Athanasou C A Wells J Quinn D P Ferguson A Heryet J O McGee 《British journal of cancer》1989,59(4):491-498
The origin and nature of osteoclast-like multinucleated giant cells (OMGCs), in extraskeletal neoplasms, is uncertain. The ultrastructure, antigenic phenotype and function of OMGCsm in a breast carcinoma were studied in order to clarify the relationship between OMGCs, osteoclasts and other cells of the mononuclear phagocyte system (MPS). OMGCs resorbed cortical bone in a manner similar to osteoclasts. However, unlike osteoclasts, OMGCs did not possess a ruffled border or clear zone, and expressed HLA-DR and Fc receptors and CD14, CD16, CD18 and CD11 (p150,95) antigens. In addition, OMGCs failed to respond morphologically to calcitonin and were directly stimulated by parathyroid hormone (PTH) to increase bone resorption. These findings suggest that OMGCs are a specific type of macrophage polykaryon distinct from both osteoclasts and other types of inflammatory polykaryon. Occasional smaller (20-25 microns) macrophage-like cells were also associated with resorption pits. Bone resorption by OMGCs isolated from the breast indicates that a cell of the MPS can be transplanted to a new tissue location and perform a highly specialised function appropriate to an MPS cell of that tissue (i.e. the osteoclast). PTH stimulation of bone resorption by OMGCs suggests that PTH or a PTH-like protein, may be involved in the bone resorption and consequent hypercalcaemia associated with metastatic breast cancer. 相似文献
980.
R. P. Heaney T. M. Zizic I. Fogelman W. P. Olszynski P. Geusens C. Kasibhatla N. Alsayed G. Isaia M. W. Davie C. H. Chesnut III 《Osteoporosis international》2002,13(6):501-505
Risedronate treatment reduces the risk of vertebral fracture in women with existing vertebral fractures, but its efficacy
in prevention of the first vertebral fracture in women with osteoporosis but without vertebral fractures has not been determined.
We examined the risk of first vertebral fracture in postmenopausal women who were enrolled in four placebo-controlled clinical
trials of risedronate and who had low lumbar spine bone mineral density (BMD) (mean T-score =–3.3) and no vertebral fractures at baseline. Subjects received risedronate 5 mg (n= 328) or placebo (n= 312) daily for up to 3 years; all subjects were given calcium (1000 mg daily), as well as vitamin D supplementation (up
to 500 IU daily) if baseline serum 25-hydroxyvitamin D levels were low. The incidence of first vertebral fracture was 9.4%
in the women treated with placebo and 2.6% in those treated with risedronate 5 mg (risk reduction of 75%, 95% confidence interval
37% to 90%; P= 0.002). The number of patients who would need to be treated to prevent one new vertebral fracture is 15. When subjects were
stratified by age, similar significant reductions were observed in patients with a mean age of 64 years (risk reduction of
70%, 95% CI 8% to 90%; P= 0.030) and in those with a mean age of 76 years (risk reduction of 80%, 95% CI 7% to 96%; P= 0.024). Risedronate treatment therefore significantly reduces the risk of first vertebral fracture in postmenopausal women
with osteoporosis, with a similar magnitude of effect early and late after the menopause.
Received: 12 September 2001 / Accepted: 11 December 2001 相似文献